Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
sodium fluoride + CXP
- Development stage
- Unknown
- Lead developer
- Patterson
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
Sodium fluoride + CXP is a dental varnish formulation that combines 5% sodium fluoride with CXP technology. It provides sustained time-release fluoride delivery and contains bioavailable calcium, phosphate, and fluoride to promote tooth remineralization and prevent dental caries. The CXP technology enhances the effectiveness of fluoride by providing essential minerals needed for the remineralization process. This formulation does not clump or separate, offering improved handling characteristics for dental professionals.
- Brand names
- Embrace Varnish
- Other names
- 5% Sodium Fluoride with CXP
02
Targets
ENO (Alpha-enolase)
Beyond the preview
Go deeper on sodium fluoride + CXP.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on sodium fluoride + CXP.